<br>The latest Access to Medicines Index reports<br>that pharmaceuticals giants are<br>changing perceptions in the developing<br>world by offering discounts, conducting<br>research on neglected diseases and being<br>more transparent in clinical trials. "It is<br>
unclear whether the price reductions are<br>enough to meaningfully increase affordability,"<br>says the report.<br>For more details at:<br><br><a href="http://www.guardian.co.uk/globaldevelopment/">http://www.guardian.co.uk/globaldevelopment/</a><br>
2012/nov/28/big-pharma-drugs-poorcountries  <br>